Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Propylthiouracil-associated hepatitis.

S A Peter1

  • 1State University of New York's Health Science Center, Brooklyn.

Journal of the National Medical Association
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Unitarian Hypothesis for the aetiology of diabetes mellitus.

Medical hypotheses·2006
Same author

Hypercalcemia associated with adult T-cell leukemia/lymphoma (ATL).

Journal of the National Medical Association·1995
Same author

2H nuclear magnetic resonance order parameter profiles suggest a change of molecular shape for phosphatidylcholines containing a polyunsaturated acyl chain.

Biophysical journal·1995
Same author

Glucocorticoid reserve in patients with acquired immunodeficiency syndrome.

Hormone research·1995
Same author

Bromocriptine-induced schizophrenia.

Journal of the National Medical Association·1993
Same author

Myxedema masking primary hyperparathyroidism.

Journal of the National Medical Association·1993
Same journal

Perioperative outcomes: Transforming healthcare.

Journal of the National Medical Association·2026
Same journal

The intersection of infectious diseases and cardiovascular disease in Africa: A narrative review.

Journal of the National Medical Association·2026
Same journal

Atrial fibrillation in chronic heart failure: prevalence and one-year outcome in the Ibadan chronic heart failure project.

Journal of the National Medical Association·2026
Same journal

Corrigendum to ``Medical student perspectives of leadership development in community engagement'' [In Press].

Journal of the National Medical Association·2026
Same journal

Ethno-racial trauma and well-being in medical education: A scoping review of U.S. physician trainees and medical students.

Journal of the National Medical Association·2026
Same journal

Cuts to medicaid and the affordable care act: Negative consequences for the black community.

Journal of the National Medical Association·2026
See all related articles

Propylthiouracil can cause liver damage (hepatitis). This case shows that liver function may worsen even after stopping the medication, highlighting a delayed reaction to drug-induced liver injury.

Area of Science:

  • Hepatology
  • Clinical Pharmacology
  • Toxicology

Background:

  • Propylthiouracil (PTU) is a medication used to treat hyperthyroidism.
  • Drug-induced liver injury (DILI) is a known adverse effect of many medications, including PTU.
  • The typical course of PTU-induced hepatitis involves improvement after drug cessation.

Observation:

  • A 43-year-old female developed propylthiouracil-induced hepatitis.
  • The patient's liver function tests showed significant deterioration 2 weeks after discontinuing propylthiouracil.
  • This delayed worsening of liver function is an unusual presentation.

Findings:

  • The case highlights a delayed hepatotoxic effect of propylthiouracil.
  • Liver function decline continued post-discontinuation, challenging typical recovery patterns.

Related Experiment Videos

  • This suggests a prolonged or delayed inflammatory process following PTU exposure.

    • Implications:

    • Clinicians should consider prolonged monitoring for liver function in patients with propylthiouracil-induced hepatitis.
    • The findings suggest a need to investigate the mechanisms behind delayed DILI.
    • This case emphasizes the importance of recognizing atypical drug reactions for patient management.